Introduction to Perrigo Company plc

Perrigo Company plc is a global healthcare leader headquartered in Dublin, Ireland, with a strategic focus on providing high-quality self-care and prescription products to consumers and healthcare systems worldwide. Founded in 1887, Perrigo has evolved from a small drugstore in Michigan into a top-tier multinational pharmaceutical company, recognized for its extensive portfolio of over-the-counter (OTC) medications, nutritional supplements, and specialty pharmaceuticals. The company operates across three primary segments: Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. With revenues exceeding $4.3 billion annually and a workforce of over 9,000 employees, Perrigo is a key player in the global healthcare industry, known for its commitment to accessibility, affordability, and innovation. The company’s reputation as a trusted partner for retailers, healthcare providers, and patients is built on decades of expertise in manufacturing, regulatory compliance, and supply chain excellence. Perrigo’s mission to make lives better by delivering quality healthcare solutions aligns with its strategic investments in research and development, digital transformation, and sustainable practices. This profile explores the company’s history, corporate values, business strategy, workplace culture, and the specific role of a Senior Regulatory Affairs Specialist within the organization.

Company History and Business Evolution

Perrigo’s journey began in 1887 when Luther Perrigo opened a small drugstore in Allegan, Michigan. The company initially focused on distributing homeopathic remedies and eventually shifted to manufacturing its own pharmaceutical products. A pivotal moment came in 1945 when Perrigo received its first patent for a generic antacid, marking the start of its leadership in the generic OTC market. Throughout the mid-20th century, Perrigo expanded through strategic acquisitions, such as the purchase of Drug Guild in 1967 and later W.E. Bassett Company, which broadened its product range into vitamins and supplements. The 1990s saw aggressive growth into international markets, with acquisitions of Galpharm Healthcare Ltd in the UK and Johnson & Johnson’s OTC business in Europe. In 2005, Perrigo acquired Agis Industries, a major Israeli pharmaceutical firm, for over $800 million, significantly boosting its prescription and dermatology capabilities. The company reorganized as Perrigo Company plc in 2013 after relocating its headquarters to Ireland for tax efficiency, though its operational heart remains in Michigan. Recent milestones include the 2020 acquisition of HRA Pharma for $1.8 billion, adding women’s health products like Ella and NorLevo to its portfolio. Perrigo has also divested non-core businesses, such as its branded consumer health business to focus on private-label and generic segments. Today, Perrigo is a top-five global OTC manufacturer, supplying products to major retailers like Walmart, CVS, and Boots. Its evolution from a small-town pharmacy to a global healthcare powerhouse reflects relentless innovation, strategic foresight, and a deep commitment to public health.

Perrigo Company plc at a Glance

• Headquarters: Dublin, Ireland (operational HQ in Allegan, Michigan, USA)
• Founded: 1887
• CEO: Patrick Lockwood-Taylor (as of 2025)
• Revenue: $4.3 billion (FY 2024)
• Employees: 9,000+ globally
• Industry: Pharmaceuticals / Consumer Healthcare
• Stock Symbol: PRGO (NYSE)
• Products: OTC medications, vitamins, supplements, prescription generics, specialty pharmaceuticals, and women’s health products.
• Global Presence: Operations in over 30 countries, manufacturing facilities in USA, UK, Israel, Germany, Mexico, and more.
• Key Brands: GoodSense™, Nicoderm® CQ, Rite Aid branded products, Ella®, NorLevo®, and many private-label equivalents.
• Regulatory Strengths: Approved by FDA, EMA, Health Canada, and other major health authorities.
• R&D Investments: Approximately $150 million annually.
• Distribution Channels: Retail chains, pharmacies, hospitals, and online marketplaces.
• Corporate Values: Quality, Integrity, Innovation, Collaboration, and Responsibility.
• Sustainability: Committed to net-zero greenhouse gas emissions by 2050.
• Awards: Recognized as a top employer in healthcare by Forbes and Great Place to Work.
• Public Trading: Listed on New York Stock Exchange since 1993.
• Recent Acquisition: HRA Pharma (2020) – strengthened women’s health portfolio.
• Market Position: #1 in private-label OTC in North America.
• Legal Structure: Public limited company (plc) incorporated in Ireland.

Mission, Vision, and Core Corporate Values

Perrigo Company plc’s mission is to make lives better by providing high-quality, affordable healthcare solutions that empower consumers to take control of their health. The company envisions a world where everyone has access to safe and effective self-care products, reducing the burden on healthcare systems and improving overall wellness. Core values include: Quality – unwavering commitment to manufacturing excellence and regulatory compliance; Integrity – ethical business practices and transparency; Innovation – continuous improvement and investment in novel formulations and delivery systems; Collaboration – working closely with partners, customers, and communities; and Responsibility – environmental stewardship and social impact. These values guide decision-making at all levels, from executive leadership to factory floor employees. Perrigo’s corporate culture emphasizes patient-centricity, with every product developed to meet real-world needs for safety, efficacy, and convenience. The company’s responsibility extends to sustainability, having pledged to reduce its carbon footprint and eliminate unnecessary plastic waste from its packaging by 2030. Mission-driven initiatives include partnerships with organizations like UNICEF to deliver essential medicines to underserved populations. By aligning its business goals with broader societal benefits, Perrigo reinforces its reputation as a responsible corporate citizen.

Business Strategy and Future Roadmap

Perrigo’s business strategy centers on strengthening its position as the leading global provider of private-label and generic OTC products. The roadmap includes four key pillars: 1) Portfolio Optimization – focusing on high-growth categories like pain relief, respiratory, gastrointestinal, and women’s health while divesting non-core assets. 2) Innovation Acceleration – increasing R&D spending to develop differentiated products, including extended-release formulations and combination therapies. 3) Supply Chain Resilience – investing in manufacturing automation and diversifying suppliers to mitigate disruptions. 4) Digital Transformation – leveraging data analytics to personalize product recommendations and streamline regulatory submissions. The company aims to achieve 5% annual revenue growth through a mix of organic growth and strategic acquisitions. Future priorities include expanding into emerging markets like China and India, where OTC self-care is growing rapidly. Perrigo also plans to enhance its direct-to-consumer (D2C) capabilities, offering subscription services for chronic condition management. Sustainability is embedded in the strategy, with a target of 100% renewable energy by 2030. By staying ahead of regulatory trends and consumer preferences, Perrigo intends to maintain its competitive edge and deliver shareholder value over the long term.

Products, Technologies, and Services

Perrigo’s product portfolio spans more than 5,000 SKUs across multiple therapeutic categories. In the Consumer Self-Care Americas segment, products include pain relievers (acetaminophen, ibuprofen), cold and flu remedies, allergy relief, digestive health, and smoking cessation aids like Nicoderm® CQ patches. The International segment offers similar products under local brands in Europe, Latin America, and Asia-Pacific. The Prescription Pharmaceuticals segment focuses on generic formulations for dermatology, women’s health, and oncology supportive care. Key technologies include controlled-release drug delivery systems, taste-masking for pediatric formulations, and sterile injectable manufacturing. Services extend beyond product sales; Perrigo provides regulatory consulting, private-label manufacturing, and supply chain management for retail partners. The company operates state-of-the-art R&D centers in the US and UK, where scientists develop novel combinations and delivery methods. For example, Perrigo pioneered the first OTC generic version of the opioid overdose reversal drug naloxone (Narcan) and launched a comprehensive pain management platform. In women’s health, the acquisition of HRA Pharma brought Ella®, a leading emergency contraceptive, and NorLevo®. Perrigo also invests in digital health tools, such as a mobile app that tracks adherence to fertility treatments. By combining pharmaceutical expertise with consumer insights, Perrigo delivers products that improve quality of life.

Industries and Markets Served

Perrigo serves primarily two interconnected markets: consumer healthcare and generic pharmaceuticals. The consumer healthcare market includes retail chains (Walmart, Target, CVS, Walgreens), supermarkets, and online pharmacies. These customers rely on Perrigo for affordable private-label alternatives to branded drugs, allowing them to offer low prices while maintaining margins. The generic pharmaceutical market serves hospitals, clinics, and specialty pharmacies, providing cost-effective prescription options for chronic conditions. Geographically, Perrigo’s main markets are North America (55% of revenue), Europe (30%), and the rest of the world (15%). The company has a strong foothold in the UK, Israel, and Germany. Additionally, Perrigo serves institutional buyers such as government health programs and insurance companies through bulk purchasing agreements. The growing trend toward self-care and generic substitution fuels demand. Perrigo also operates in the private-label supply market, where it competes with other contract manufacturers but differentiates through scale and regulatory expertise. Emerging opportunities include veterinary health and CBD-infused products, though regulatory hurdles remain. By diversifying across geographies and customer segments, Perrigo mitigates risks and capitalizes on global health trends.

Leadership and Management Philosophy

Perrigo’s leadership team is composed of industry veterans with deep pharmaceutical and consumer goods experience. CEO Patrick Lockwood-Taylor, appointed in 2021, previously served as CEO of Reckitt Benckiser’s health division. The management philosophy emphasizes accountability, transparency, and empowerment. Leaders are expected to drive results while fostering a culture of safety and compliance. The company operates a decentralized structure, allowing business units to respond quickly to market changes. Regular town halls and open-door policies encourage employee feedback. Performance is measured using balanced scorecards that include financial, operational, and sustainability metrics. Perrigo invests in leadership development programs, such as the Perrigo Executive Academy, which prepares high-potential managers for senior roles. The board of directors includes experts in finance, healthcare, and regulatory affairs, ensuring robust governance. The philosophy is summed up by the motto: “We do the right thing, every time.” This approach has helped Perrigo navigate complex regulatory environments and maintain trust with stakeholders.

Corporate Events, Conferences, and Community Engagement

Perrigo actively participates in industry conferences like the Consumer Healthcare Products Association (CHPA) Annual Meeting, Drug Information Association (DIA) Annual Meeting, and the Generic Pharmaceutical Association (GPhA) events. The company also hosts its own Perrigo Innovation Summit, showcasing new product developments and strategic partnerships. Community engagement is a priority; Perrigo sponsors health education programs and free wellness screenings in underserved communities. The Perrigo Foundation, established in 2010, has donated over $20 million to causes such as disaster relief, childhood nutrition, and healthcare access. Employees volunteer thousands of hours annually through paid time off for volunteering. Notable initiatives include “Perrigo Cares Day” where teams pack hygiene kits for homeless shelters. The company also partners with universities for STEM education and research collaborations. These activities reinforce Perrigo’s brand as a caring corporate neighbor and attract talent seeking purpose-driven work.

Employees and Workplace Culture

Perrigo employs over 9,000 people worldwide, with a diverse workforce spanning scientists, engineers, supply chain experts, and corporate professionals. The workplace culture emphasizes inclusion, wellness, and continuous learning. Employee resource groups (ERGs) for women, veterans, and LGBTQ+ employees provide support and networking opportunities. The company offers competitive compensation, including stock options, bonuses, and comprehensive health benefits. Flexible working arrangements and remote options are available for eligible roles. Training programs cover regulatory updates, leadership skills, and technical certifications. Perrigo has been recognized as a “Top Employer” by the Science & Technology Council and maintains high employee engagement scores. The company’s turnover rate is below industry average, reflecting strong retention. Safety is paramount; manufacturing facilities follow strict OSHA and FDA guidelines, with zero-tolerance for violations. Perrigo’s open communication culture encourages innovation, as seen in its employee suggestion program that has led to cost-saving process improvements. Overall, working at Perrigo means being part of a mission-driven organization that values its people as its greatest asset.

Job Details & Requirements for this Posting

Role: Senior Regulatory Affairs Specialist

As a Senior Regulatory Affairs Specialist at Perrigo Company plc, you will lead regulatory strategies for OTC and prescription products across global markets. Responsibilities include: preparing and submitting regulatory filings (NDA, ANDA, OTC monographs) to FDA, EMA, and other health authorities; reviewing labeling and promotional materials for compliance; coordinating with cross-functional teams to align regulatory requirements with product development timelines; monitoring changes in regulations and advising on impact; and mentoring junior staff. Qualifications: Bachelor’s degree in life sciences (pharmacy, chemistry, biology) required; advanced degree preferred. Minimum 5 years of regulatory experience in the pharmaceutical industry, with expertise in OTC or generic drugs. Strong knowledge of FDA 21 CFR parts 210/211, ICH guidelines, and ISO standards. Experience with international submissions (EU, Canada, Australia) highly valued. Excellent communication skills and ability to manage multiple projects simultaneously. Why join Perrigo? You’ll work on products that directly improve consumers’ health, be part of a globally recognized company with a strong track record of regulatory approvals, and enjoy competitive salary plus performance bonuses, stock options, and a supportive team environment. Career progression opportunities include leading a regulatory team or transitioning into global policy roles.

Customer Reviews and Industry Reputation

Perrigo enjoys a solid reputation among customers, partners, and employees, though like any large corporation, it receives mixed reviews. Below is an exhaustive analysis across major review platforms.

Glassdoor

On Glassdoor, Perrigo Company plc holds a 3.7 out of 5 rating based on over 4,000 reviews. Employees praise the company’s strong market position, quality products, and opportunities for advancement. Many highlight the collaborative culture and supportive managers. Common positives include good work-life balance (especially in R&D roles) and competitive pay. Negative feedback often mentions bureaucracy, slow decision-making, and limited remote work options in manufacturing roles. Some reviews note occasional layoffs during restructuring. Overall, 74% of employees would recommend Perrigo to a friend, and the CEO approval rating is 70%.

Indeed

On Indeed, Perrigo has a 3.6 rating with over 2,000 reviews. Positive comments focus on the meaningful work – “knowing your products help people” – and strong benefits (401k match, health insurance). Employees appreciate the training opportunities. Critics cite high pressure in production roles, inconsistent communication from management, and limited career growth at smaller satellite plants. The overall sentiment is cautiously positive, with many recommending the company for mid-career professionals looking for stability.

Gartner Peer Insights

Gartner Peer Insights scores Perrigo as 4.2 out of 5 for its enterprise resource planning (ERP) and supply chain capabilities. IT leaders praise the company’s digital transformation initiatives and data analytics tools. However, some note legacy systems in older facilities. As a regulatory specialist, you’ll interact with these systems daily; reviews suggest the company is investing heavily in modernization.

Trustpilot

Trustpilot reviews for Perrigo’s consumer products are largely positive (4.4 stars). Customers value the affordability of private-label alternatives to major brands. Common praise: “works just as well as the name brand for half price.” Negative reviews occasionally cite inconsistent quality in packaging or occasional allergen contamination, but these are rare. The company responds to complaints quickly.

G2

G2 focuses on B2B software; Perrigo’s internal tools for regulatory compliance receive a 4.0 rating. Users find the systems user-friendly but wish for better integration with external databases.

Google Reviews

Google Reviews for Perrigo’s corporate office in Allegan, MI (4.2 stars) highlight a pleasant work environment, modern facilities, and good cafeteria. Visitors also note the company’s involvement in local charity events.

LinkedIn Reputation

LinkedIn rates Perrigo as a top company in pharmaceuticals, with 880,000 followers. The page features employee stories, product launches, and sustainability updates. Engagement is high, with many alumni recommending the company for its learning opportunities.

Why Organizations Choose Perrigo Company plc

Retailers and healthcare providers choose Perrigo for its unmatched expertise in private-label OTC manufacturing. The company offers end-to-end solutions: product development, regulatory clearance, scalable production, and reliable logistics. Perrigo’s close relationships with regulators ensure faster time-to-market for generic products. Customers trust the consistent quality, backed by over a century of experience. Additionally, Perrigo’s commitment to sustainability appeals to environmentally conscious buyers. The company’s financial stability – with investment-grade credit ratings – provides assurance of long-term partnership. For pharmaceutical companies, Perrigo is a preferred collaborator for co-developing specialized formulations. Overall, choosing Perrigo means gaining a partner that understands local market nuances and global trends.

Official Contact Information

For inquiries and assistance, please reach out to Perrigo Company plc using the following contact details:

Address: Perrigo Company plc, 1 Grand Canal Square, Docklands, Dublin 2, D02 P820, Ireland
Contact Number: +353 1 697 3000
Support Number: +1-800-719-9260 (USA)
Helpdesk Number: +44 800 032 4001 (UK)
Website: https://www.perrigo.com

Official Social Media Presence

• LinkedIn: Perrigo Company plc on LinkedIn
• Twitter: @PerrigoCareers
• Facebook: PerrigoCompany
• Instagram: @perrigocareers
• YouTube: Perrigo Company Channel

SEO FAQ Section

Perrigo Company plc specializes in the development, manufacturing, and distribution of over-the-counter (OTC) medications, generic prescription drugs, and nutritional products. The company is a leading provider of private-label health products globally.

Perrigo Company plc is headquartered in Dublin, Ireland, with major operational facilities in Allegan, Michigan, USA.

As of 2025, Perrigo Company plc employs approximately 9,000 people across more than 30 countries.

Yes, Perrigo Company plc is listed on the New York Stock Exchange under the ticker symbol PRGO.

The CEO of Perrigo Company plc is Patrick Lockwood-Taylor, who has served since 2021.

Perrigo Company plc produces a wide range of products including pain relievers, cough and cold remedies, allergy medications, digestive aids, smoking cessation products, women’s health treatments, and generic prescription drugs.

Yes, Perrigo Company plc has manufacturing facilities in the UK, Israel, Germany, Mexico, and other countries, supporting its global supply chain.

Perrigo Company plc reported annual revenue of approximately $4.3 billion for the fiscal year 2024.

Perrigo Company plc adheres to stringent regulatory standards set by the FDA, EMA, and other health authorities, with robust quality management systems and regular audits.

Absolutely. Perrigo Company plc frequently hires regulatory affairs specialists, scientists, and compliance experts to manage its extensive product portfolio and global filings.

Perrigo Company plc fosters a collaborative, inclusive culture with a focus on innovation, safety, and employee well-being. It offers flexible work options for many roles.

Interested candidates can view open positions and apply through the official Perrigo Company plc website’s careers section or on LinkedIn.

Yes, the Perrigo Foundation supports health education, disaster relief, and community health programs, having donated over $20 million since its inception.

Perrigo Company plc is committed to achieving net-zero emissions by 2050 and reducing plastic waste by 2030, with several green initiatives underway.

Perrigo’s private-label products are sold in major retailers such as Walmart, CVS, Walgreens, Target, Boots, and many online platforms.

Yes, Perrigo competes with companies like Teva, Mylan (Viatris), and Lannett, but its focus on private-label OTC and strong retail relationships give it a distinct advantage.

Salaries vary by position and location, but the Senior Regulatory Affairs Specialist role offers a base range of $95,000 to $130,000 plus bonuses and stock options.

Yes, Perrigo invests heavily in professional development through the Perrigo Executive Academy, online courses, and conference attendance support.

Investor inquiries can be directed to the corporate headquarters in Dublin or through the investor relations page on the official website.

A tailored resume highlighting regulatory experience, a cover letter explaining your interest in the company, and any relevant certifications (RAC, CQA) will strengthen your application.

Perrigo Company plc is a trusted name in healthcare, and industry professionals can explore additional resources such as Paid Guest Posting Sites to enhance their digital visibility. For a broader understanding of corporate compliance and regulatory frameworks, visiting the official Perrigo Company plc website provides in-depth insights into the company’s operations, leadership, and career opportunities. This synergistic approach combines industry-specific knowledge with quality content placement.